155 related articles for article (PubMed ID: 19037646)
1. [Current ophthalmic aspects of acute retinopathy of prematurity].
Lorenz B
Ophthalmologe; 2008 Dec; 105(12):1092-100. PubMed ID: 19037646
[TBL] [Abstract][Full Text] [Related]
2. Retinopathy of prematurity.
Jordan CO
Pediatr Clin North Am; 2014 Jun; 61(3):567-77. PubMed ID: 24852153
[TBL] [Abstract][Full Text] [Related]
3. [New therapeutic approaches in the treatment of retinopathy of prematurity].
Jandeck C
Klin Monbl Augenheilkd; 2009 Nov; 226(11):914-20. PubMed ID: 19798624
[TBL] [Abstract][Full Text] [Related]
4. [VEGF antibodies as therapy for retinopathy of prematurity].
Oberacher-Velten IM; Helbig H
Klin Monbl Augenheilkd; 2010 Sep; 227(9):694-700. PubMed ID: 20845249
[TBL] [Abstract][Full Text] [Related]
5. Retinopathy of prematurity: diagnosis and management [continuing education credit].
Vander JF
J Ophthalmic Nurs Technol; 1994; 13(5):207-12; quiz 238-9. PubMed ID: 7983684
[TBL] [Abstract][Full Text] [Related]
6. Iris rubeosis, severe respiratory failure and retinopathy of prematurity--case report.
Modrzejewska M; Kulik U; Lubiński W
Ginekol Pol; 2014 Jan; 85(1):70-3. PubMed ID: 24505969
[TBL] [Abstract][Full Text] [Related]
7. Intravitreal bevacizumab versus laser treatment in type 1 retinopathy of prematurity: report on fluorescein angiographic findings.
Lepore D; Quinn GE; Molle F; Baldascino A; Orazi L; Sammartino M; Purcaro V; Giannantonio C; Papacci P; Romagnoli C
Ophthalmology; 2014 Nov; 121(11):2212-9. PubMed ID: 25001158
[TBL] [Abstract][Full Text] [Related]
8. Retinopathy of prematurity: do we still have a problem?: the Charles L. Schepens lecture.
Tasman W
Arch Ophthalmol; 2011 Aug; 129(8):1083-6. PubMed ID: 21825195
[TBL] [Abstract][Full Text] [Related]
9. [Effects of intravitreal pegaptanib or bevacizumab and laser in treatment of threshold retinopathy of prematurity in zone I and posterior zone II--four years results].
Autrata R; Senková K; Holousová M; Krejcírová I; Dolezel Z; Borek I
Cesk Slov Oftalmol; 2012 Feb; 68(1):29-36. PubMed ID: 22679695
[TBL] [Abstract][Full Text] [Related]
10. Time to consider a new treatment protocol for aggressive posterior retinopathy of prematurity?
Spandau U; Tomic Z; Ewald U; Larsson E; Akerblom H; Holmström G
Acta Ophthalmol; 2013 Mar; 91(2):170-5. PubMed ID: 22268644
[TBL] [Abstract][Full Text] [Related]
11. Outcomes after Intravitreal Bevacizumab versus Laser Photocoagulation for Retinopathy of Prematurity: A 5-Year Retrospective Analysis.
Hwang CK; Hubbard GB; Hutchinson AK; Lambert SR
Ophthalmology; 2015 May; 122(5):1008-15. PubMed ID: 25687024
[TBL] [Abstract][Full Text] [Related]
12. Vitreous levels of erythropoietin and vascular endothelial growth factor in eyes with retinopathy of prematurity.
Sato T; Kusaka S; Shimojo H; Fujikado T
Ophthalmology; 2009 Sep; 116(9):1599-603. PubMed ID: 19371954
[TBL] [Abstract][Full Text] [Related]
13. Increase in treatment of retinopathy of prematurity in the Netherlands from 2010 to 2017.
Trzcionkowska K; Vehmeijer WBHJ; Kerkhoff FT; Bauer NJC; Bennebroek CAM; Dijk PH; Dijkman KP; van den Dungen FAM; Eggink CA; Feenstra RPG; Groenendaal F; van Heijst AF; van der Hoeven MAHBM; Kornelisse RF; Kraal-Biezen E; Lopriore E; Onland W; Renardel de Lavalette VW; van Rijn LJ; Schuerman FABA; Simonsz HJ; Voskuil-Kerkhof ESM; Witlox RSGM; Termote JUM; Schalij-Delfos NE
Acta Ophthalmol; 2021 Feb; 99(1):97-103. PubMed ID: 32701185
[TBL] [Abstract][Full Text] [Related]
14. Refractive outcomes following bevacizumab monotherapy compared with conventional laser treatment: a randomized clinical trial.
Geloneck MM; Chuang AZ; Clark WL; Hunt MG; Norman AA; Packwood EA; Tawansy KA; Mintz-Hittner HA;
JAMA Ophthalmol; 2014 Nov; 132(11):1327-33. PubMed ID: 25103848
[TBL] [Abstract][Full Text] [Related]
15. Screening premature infants for retinopathy of prematurity in a tertiary hospital in Saudi Arabia.
Mgharbil E; Raffa LH; Alessa S; Alamri A
Ann Saudi Med; 2020; 40(2):87-93. PubMed ID: 32241163
[TBL] [Abstract][Full Text] [Related]
16. Successful Surgical Management of Retinopathy of Prematurity Showing Rapid Progression despite Extensive Retinal Photocoagulation.
Gadkari SS; Kulkarni SR; Kamdar RR; Deshpande M
Middle East Afr J Ophthalmol; 2015; 22(3):393-5. PubMed ID: 26180484
[TBL] [Abstract][Full Text] [Related]
17. Combination of laser photocoagulation and intravitreal bevacizumab (Avastin) for aggressive zone I retinopathy of prematurity.
Chung EJ; Kim JH; Ahn HS; Koh HJ
Graefes Arch Clin Exp Ophthalmol; 2007 Nov; 245(11):1727-30. PubMed ID: 17690897
[TBL] [Abstract][Full Text] [Related]
18. Increased incidence of retinopathy of prematurity and evolving treatment modalities at a Canadian tertiary centre.
Isaza G; Donaldson L; Chaudhary V
Can J Ophthalmol; 2019 Apr; 54(2):269-274. PubMed ID: 30975353
[TBL] [Abstract][Full Text] [Related]
19. ANALYSIS OF CHANGES IN CHARACTERISTICS OF SEVERE RETINOPATHY OF PREMATURITY PATIENTS AFTER SCREENING GUIDELINES WERE ISSUED IN CHINA.
Chen Y; Feng J; Li F; Yin H; Liang J; Li X
Retina; 2015 Aug; 35(8):1674-9. PubMed ID: 25719989
[TBL] [Abstract][Full Text] [Related]
20. RATES AND RISK FACTORS FOR RECURRENCE OF RETINOPATHY OF PREMATURITY AFTER LASER OR INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR MONOTHERAPY.
Ling KP; Liao PJ; Wang NK; Chao AN; Chen KJ; Chen TL; Hwang YS; Lai CC; Wu WC
Retina; 2020 Sep; 40(9):1793-1803. PubMed ID: 31800460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]